Show simple item record

dc.date.accessioned2018-01-29T19:49:40Z
dc.date.available2018-01-29T19:49:40Z
dc.date.issued2016-12
dc.identifier.urihttp://hdl.handle.net/10713/7428
dc.descriptionProgram of the meeting sponsored by the Fondation Mérieux held in Veyrier-du-lac, France, December 5-7, 2016. The primary goal was to discuss various aspects of the Full Public Health Value (FPHV) of vaccines. Selected topics for discourse include: 1) the definition of FPHV; 2) a review of examples of the FPHV of existing vaccines; 3) to propose measures and outcomes for assessing the FPHV of vaccines in phase III trials; and, 4) strategize on how to communicate the FPHV of vaccines to regulatory and program policy makersen_US
dc.language.isoen_USen_US
dc.subjectfull public health value (FPHV)en_US
dc.subject.lcshFondation Mérieuxen_US
dc.subject.lcshPublic Health Servicesen_US
dc.subject.meshGlobal Healthen_US
dc.subject.meshPublic Healthen_US
dc.subject.meshVaccinesen_US
dc.titleEstimating the full public health value of vaccinesen_US
dc.typeConference/Congressen_US
refterms.dateFOA2019-02-19T18:35:44Z


Files in this item

Thumbnail
Name:
FondationMeieuxEventLaurensNeu ...
Size:
1.368Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record